asphd2 Antibody

What is ASPHD2 and what cellular functions is it involved in?

ASPHD2 is a protein involved in various cellular processes including gene expression regulation and cell growth. It is believed to function as a 2-oxoglutarate-dependent dioxygenase . Research indicates that ASPHD2 may play crucial roles in:

• Chromatin organization and epigenetic regulation

• Gene silencing and transcriptional regulation

• Cancer progression processes

• Viral propagation, specifically in hepatitis B virus

• Fertility processes, particularly in relation to sperm hyperactivation

Molecularly, ASPHD2 contains aspartate beta-hydroxylase domains, which are indicative of its enzymatic function. Recent studies suggest it may be involved in the hydroxylation of specific protein targets, though the complete range of substrates remains under investigation.

Validating antibody specificity is crucial for experimental reliability. For ASPHD2 antibodies, consider these validation methods:

• Positive and negative controls: Use cell lines known to express ASPHD2 (e.g., HeLa, HL60) compared to those with low expression .

• Western blot confirmation: Look for a specific band at approximately 42 kDa, which is the predicted molecular weight of ASPHD2 .

• Knockdown or knockout validation: Compare results from wild-type samples versus ASPHD2 knockdown/knockout samples to confirm specificity.

• Immunogen peptide competition: Pre-incubate the antibody with the immunogen peptide before application to verify signal elimination.

• Cross-reactivity assessment: If working with non-human samples, verify reactivity with your species of interest. Some ASPHD2 antibodies show cross-reactivity with multiple species including mouse, rat, and other mammals .

• Multiple antibody concordance: Use different antibodies targeting distinct epitopes of ASPHD2 and compare results for consistency.

What are the optimal conditions for using ASPHD2 antibodies in Western Blot analysis?

For optimal Western Blot results with ASPHD2 antibodies:

• Sample preparation:

  • Use whole cell lysates from relevant cell types (e.g., HeLa, HL60)

  • Include protease inhibitors to prevent degradation

• Protein loading and separation:

  • Load 20-30 μg of total protein per lane

  • Use 10-12% SDS-PAGE gels for optimal separation

• Transfer conditions:

  • Standard PVDF or nitrocellulose membranes are suitable

  • Transfer at 100V for 1 hour or 30V overnight at 4°C

• Blocking:

  • 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

• Primary antibody incubation:

  • Dilute ASPHD2 antibody 1:500-1:2000 in blocking buffer

  • Incubate overnight at 4°C with gentle agitation

• Detection:

  • Use species-appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG)

  • Dilute secondary antibody 1:5000-1:10000

  • Expected band size: 42 kDa

• Troubleshooting:

  • If background is high, increase washing steps or adjust antibody dilution

  • If signal is weak, consider longer exposure times or signal enhancement systems

For optimal immunohistochemistry results with ASPHD2 antibodies:

• Tissue preparation and fixation:

  • 10% neutral buffered formalin fixation for 24-48 hours is standard

  • Paraffin embedding with standard protocols

• Antigen retrieval:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

  • Pressure cooker treatment for 10-15 minutes or microwave for 20 minutes

• Blocking and permeabilization:

  • Block with 5-10% normal serum (from secondary antibody host species)

  • Include 0.1-0.3% Triton X-100 for membrane permeabilization

• Primary antibody incubation:

  • Dilute ASPHD2 antibody 1:200-1:500

  • Incubate overnight at 4°C in a humidified chamber

• Detection system:

  • Use appropriate HRP-conjugated or fluorescently-labeled secondary antibody

  • Consider tyramide signal amplification for low-abundance targets

• Counterstaining and mounting:

  • Hematoxylin counterstain for brightfield

  • DAPI for fluorescent applications

  • Use antifade mounting medium for fluorescence applications

• Controls:

  • Include positive control tissues known to express ASPHD2

  • Include negative controls (primary antibody omitted, isotype control)

What are the best approaches for studying ASPHD2's role in epigenetic regulation?

ASPHD2 has been implicated in chromatin organization and epigenetic regulation . To study these functions:

• Chromatin Immunoprecipitation (ChIP):

  • Use ASPHD2 antibodies to identify genomic regions where ASPHD2 is bound

  • Follow with sequencing (ChIP-seq) or qPCR for target identification

  • Cross-link cells with 1% formaldehyde for 10 minutes at room temperature

  • Use sonication to shear chromatin to 200-500 bp fragments

  • Immunoprecipitate with ASPHD2 antibody overnight at 4°C

• Co-immunoprecipitation (Co-IP):

  • Identify ASPHD2 interaction partners in epigenetic complexes

  • Use cell lysates prepared in non-denaturing conditions

  • Immunoprecipitate with ASPHD2 antibody and identify interacting proteins by mass spectrometry or Western blot

• Proximity Ligation Assay (PLA):

  • Visualize interactions between ASPHD2 and other epigenetic regulators in situ

  • Requires antibodies against both ASPHD2 and potential interacting partners

• Gene expression analysis after ASPHD2 manipulation:

  • Compare transcriptome changes (RNA-seq) after ASPHD2 knockdown/overexpression

  • Focus on genes involved in epigenetic regulation pathways

• Histone modification analysis:

  • Assess changes in histone modifications after ASPHD2 manipulation

  • Use ChIP-seq with antibodies against specific histone marks

How can ASPHD2 antibodies be used to investigate disease mechanisms?

ASPHD2 has been implicated in several disease processes. Here are methodological approaches for investigation:

• Cancer research applications:

  • Compare ASPHD2 expression between normal and cancer tissues using IHC

  • Correlate expression levels with clinical outcomes and cancer progression

  • Investigate ASPHD2's role in gene silencing and transcriptional regulation in cancer cells

• Viral infection studies:

  • Examine ASPHD2's role in hepatitis B virus propagation

  • Use antibody-based detection methods to track ASPHD2 expression changes during infection

  • Combine with viral load measurements to establish correlations

• Reproductive biology:

  • Investigate ASPHD2's function in sperm hyperactivation and fertility

  • Use immunofluorescence to localize ASPHD2 in sperm cells

  • Combine with functional fertility assays

• Tissue expression profiling:

  • Create expression maps across normal and pathological tissues

  • Use multiplexed IHC to correlate ASPHD2 expression with other disease markers

• Functional validation in disease models:

  • Monitor the effects of ASPHD2 manipulation on disease progression in model systems

  • Use antibodies to confirm knockdown/overexpression efficiency

What stability and degradation issues should I consider when working with ASPHD2?

Since ASPHD2 contains aspartate domains, it's relevant to consider degradation issues that may affect both the protein itself and antibody performance:

• Protein stability considerations:

  • Aspartate residues can undergo isomerization, particularly in conditions of higher pH and temperature

  • Asparagine residues may undergo deamidation, which can affect antibody recognition

  • These modifications can potentially affect epitope recognition, especially in complementarity-determining regions (CDRs)

• Sample preparation recommendations:

  • Use freshly prepared samples when possible

  • Include protease inhibitors in all buffers

  • Maintain consistent pH (typically 7.2-7.4) to minimize aspartate isomerization

  • Store samples at -80°C for long-term storage, avoiding repeated freeze-thaw cycles

• Antibody stability:

  • Store ASPHD2 antibodies according to manufacturer recommendations (typically 4°C short-term or -20°C long-term)

  • For long-term storage, aliquot antibodies to avoid repeated freeze-thaw cycles

  • Some manufacturers provide glycerol and preservatives in storage buffers to maintain antibody stability

• Methodology adaptations:

  • Consider accelerated stability testing if researching therapeutic applications

  • For structural studies, assess potential degradation sites when interpreting results

  • When studying ASPHD2 itself, consider its susceptibility to post-translational modifications

How can I optimize ASPHD2 antibody-based assays for quantitative analysis?

For precise quantitative analysis of ASPHD2 expression:

• Quantitative Western Blot:

  • Include recombinant ASPHD2 protein standards at known concentrations

  • Use a housekeeping protein (e.g., β-actin, GAPDH) for normalization

  • Employ digital imaging systems with linear dynamic range

  • Ensure signal intensities fall within the linear range of detection

  • Perform at least three biological replicates

• ELISA optimization:

  • For sandwich ELISA, use antibodies targeting different ASPHD2 epitopes

  • Recommended dilutions: 1:2000-1:10000 for primary antibody

  • Generate standard curves using recombinant ASPHD2 protein

  • Analyze data using four-parameter logistic regression

• Quantitative immunohistochemistry:

  • Use automated staining platforms for consistency

  • Implement digital image analysis for objective quantification

  • Include calibration slides with known quantities of target

  • Consider multiplex staining to normalize for tissue area/cell number

• Flow cytometry considerations:

  • Optimize fixation and permeabilization for intracellular ASPHD2 detection

  • Use appropriately conjugated antibodies (FITC, PE, APC)

  • Include fluorescence minus one (FMO) controls

  • Use quantitative beads for standardization across experiments

• Technical validation:

  • Verify linearity across the expected concentration range

  • Assess intra- and inter-assay coefficients of variation (CV <15% is desirable)

  • Determine limits of detection and quantification